These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3942809)

  • 1. [Characteristics of the "no-reflow" phenomenon in reperfusion of the myocardium depending upon the duration of ischemia].
    Kogan AKh; Mieégombyn A; Losev NI; Kudrin AN
    Biull Eksp Biol Med; 1986 Jan; 101(1):16-8. PubMed ID: 3942809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion.
    Reffelmann T; Kloner RA
    Basic Res Cardiol; 2006 Sep; 101(5):359-72. PubMed ID: 16915531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No reflow phenomenon in coronary heart disease.
    Ito H
    J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No-reflow phenomenon and acute myocardial ischemia. The need for further investigation.
    Camilleri JP; Fabiani JN
    Biomedicine; 1977 Dec; 26(6):353-6. PubMed ID: 606301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "no-reflow" phenomenon after temporary coronary occlusion in the dog.
    Kloner RA; Ganote CE; Jennings RB
    J Clin Invest; 1974 Dec; 54(6):1496-508. PubMed ID: 4140198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
    Vasilevskaia TA; Litvitskiĭ PF
    Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of platelet membrane glycoprotein II b/III a receptor activation in no-reflow after myocardial reperfusion].
    Feng JH; Lai WY; Ou WC; Liu J; Bin JP; Liu YL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):888-91. PubMed ID: 13129710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microcirculation of skeletal muscle after ischemia and reperfusion].
    Menger MD; Messmer K
    Wien Med Wochenschr; 1993; 143(7-8):148-58. PubMed ID: 8379164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sympathetic and parasympathetic regulation of the heart in transitory coronary insufficiency].
    Litvitskiĭ PF
    Biull Eksp Biol Med; 1990 Jan; 109(1):18-20. PubMed ID: 2110486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion.
    Jones SM; Thurman RG
    Hepatology; 1996 Jul; 24(1):163-8. PubMed ID: 8707257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts.
    Ganote CE; Humphrey SM
    Am J Pathol; 1985 Jul; 120(1):129-45. PubMed ID: 4014439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the size of the myocardial damaged area in postischemic reperfusion].
    Kogan AKh; Losev NI; Kudrin AN; Mieégombyn A
    Biull Eksp Biol Med; 1984 Mar; 97(3):270-2. PubMed ID: 6704514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular in vivo assessment of reperfusion injury: significance of prostaglandin E(1) and I(2) in postischemic "no-reflow" and "reflow-paradox".
    Tauber S; Menger MD; Lehr HA
    J Surg Res; 2004 Jul; 120(1):1-11. PubMed ID: 15172184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
    Chen H; Zhang YC; Li D; Phillips MI; Mehta P; Shi M; Mehta JL
    J Pharmacol Exp Ther; 2000 Aug; 294(2):722-7. PubMed ID: 10900253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fish oil diet minimizes hepatic reperfusion injury in the low-flow, reflow liver perfusion model.
    Zhong Z; Thurman RG
    Hepatology; 1995 Sep; 22(3):929-35. PubMed ID: 7657301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary bypass during reperfusion after coronary occlusion attenuates the "no reflow" phenomenon in ischemic myocardium.
    Uretzky G; Franco KL; Paolini D; Cohn LH
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):870-6. PubMed ID: 6602250
    [No Abstract]   [Full Text] [Related]  

  • 17. Pentoxifylline reduces venular leukocyte adherence ("reflow paradox") but not microvascular "no reflow" in hepatic ischemia/reperfusion.
    Müller JM; Vollmar B; Menger MD
    J Surg Res; 1997 Jul; 71(1):1-6. PubMed ID: 9271270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection.
    Hearse DJ; Maxwell L; Saldanha C; Gavin JB
    J Mol Cell Cardiol; 1993 Jul; 25(7):759-800. PubMed ID: 8230241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different durations of total warm ischemia of the gut on rat mesenteric microcirculation.
    Beuk RJ; Heineman E; Tangelder GJ; Kurvers HA; Bonke HJ; oude Egbrink MG
    J Surg Res; 1997 Nov; 73(1):14-23. PubMed ID: 9441787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of vasospasm and capillary no-reflow by ischemic preconditioning in skeletal muscle.
    Wang WZ; Anderson G; Maldonado C; Barker J
    Microsurgery; 1996; 17(6):324-9. PubMed ID: 9308717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.